A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model

• Ellen K. Wasan,

  Affiliation School of Health Sciences, British Columbia Institute of Technology, Burnaby, Canada

  ⨯
• Pavel Gershkovich,

  Affiliation Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

  ⨯
• Jinying Zhao,

  Affiliation Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

  ⨯
• Xiaohua Zhu,

  Affiliation Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Karl Werbovetz,

  Affiliation Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Richard R. Tidwell,

  Affiliation Department of Pathology and Lab Medicine, Consortium for Parasitic Drug Development, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• John G. Clement,

  Affiliation iCo Therapeutics Inc., Vancouver, Canada

  ⨯
• Sheila J. Thornton,

  Affiliation Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

  ⨯
• Kishor M. Wasan

  * E-mail: kwasan@interchange.ubc.ca

  Affiliation Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

  ⨯